Cancer clinical trials in the region Provence-Alpes-Côte d'Azur

212 currently recruiting clinical trials
Region Provence-Alpes-Côte d'Azur

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR
Bristol-Myers Squibb
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Phase 3 Lung cancer
#NCT06635824
NSCLC (Non-Small Cell Lung Cancer) Metastatic PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) 1 2 Immunotherapy Chemotherapy
ALK BRAF EGFR KRAS G12C KRAS non G12C MET RET ROS-1 Systemic Treatment-Naive Car-T
Hôpital Sainte Musse (Toulon), Hôpital de la Timone AP-HM (Marseille), Institut Sainte Catherine (Avignon)
Genmab
Phase 3 Lung cancer
#NCT05555732
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced Metastatic PDL1 Negative (< 1%) PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) None Systemic Treatment-Naive
Immunotherapy Bispecific T-cell engager antibodies Antibody Drug Conjugates (ADC) Immunotherapy Bispecific T-cell engager antibodies Antibody Drug Conjugates (ADC)
Hôpital Nord de Marseille (Marseille Cedex 20), Institut Paoli-Calmettes (Marseille), Institut Sainte Catherine (Avignon)
Daiichi Sankyo
Phase 3 Bladder / Urinary Tract / Urethral cancer
#NCT05024773
Non-invasive bladder cancer Urothelial carcinoma Localized 1 Immunotherapy
Systemic Treatment-Naive Systemic Treatment-Naive
Institut Paoli-Calmettes (Marseille)
Fidia Farmaceutici s.p.a.
Phase 3 Bladder / Urinary Tract / Urethral cancer
#NCT05911295
Invasive bladder cancer Upper excretory tract cancer Urethral cancer Urothelial carcinoma Locally Advanced Metastatic HER2 None Systemic Treatment-Naive
Immunotherapy
Institut Paoli-Calmettes (Marseille), Centre Antoine Lacassagne (Nice)
Seagen
Phase 3 Lymphoma CLL & Richter's syndrome
#NCT06428019
B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Lymphocytic lymphoma > 60 ml/min 50-60 ml/min 30-50 ml/min Systemic Treatment-Naive
Centre Antoine Lacassagne (Nice)
Abbvie